What is the ticker symbol for Belite Bio, Inc?

Belite Bio, Inc trades under the ticker BLTE on NASDAQ.

What sector does Belite Bio, Inc operate in?

Belite Bio, Inc is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BLTE in a portfolio?

PortView shows BLTE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Belite Bio, Inc (BLTE) Stock Analysis

NASDAQHealthcareBiotechnology

$162.71+3.84%

1-year price historyRange $63.51 – $190.30

52-week range$162.71

$63.51$200.00

What Belite Bio, Inc does

Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its flagship drug candidate, LBS-008, is an investigational oral medication administered once daily. Currently undergoing Phase 3 clinical trials, LBS-008 is engineered to modulate vitamin A delivery to the eye, thus preventing the accumulation of detrimental vitamin A metabolites in ocular tissues. Furthermore, Belite Bio is advancing LBS-009, an oral anti-retinol binding protein 4 therapy, through preclinical development. This therapy targets various liver ailments, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Founded in 2016, Belite Bio, Inc. is headquartered in San Diego, California, and operates as a subsidiary of Lin Bioscience International Ltd.

Key metrics

Market cap

$6.52B

P/E (TTM)

-87.01

EPS (TTM)

$-1.87

Beta

-1.23

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$156.63

200-day avg

$156.99

52-week high

$200.00

52-week low

$63.51

CEO

Yu-Hsin Lin

ETFs linked to BLTE

Broad-market and Healthcare sector ETFs an investor holding Belite Bio, Inc is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how BLTE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BLTE in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Belite Bio, Inc?: Belite Bio, Inc trades under the ticker BLTE on NASDAQ.
Which exchange is BLTE listed on?: BLTE is listed on NASDAQ.
What sector does Belite Bio, Inc operate in?: Belite Bio, Inc is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze BLTE in a portfolio?: PortView shows BLTE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.